Goeltz II Robert C. — SEC Form 4 filings
SEC reporting owner CIK 1653881. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-25 to 2026-05-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 40,571 shares, $909,801 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 7,763 shares @ $25.63 ($198,966) in Arcus Biosciences, Inc., filed 2026-05-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | Chief Financial Officer | 11 | — | 7 legs · 40,571 sh · $909,801 | 8 |
Form 4 filings — Goeltz II Robert C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-12 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 7,763 @ $25.63 | EDGAR |
| 2026-01-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 24,000 @ $0 · Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 6,552 @ $23.38 | EDGAR |
| 2025-12-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 6,702 @ $21.88 · Sale (S): 5,960 @ $22.16 | EDGAR |
| 2025-11-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 5,000 @ $25 | EDGAR |
| 2025-10-29 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 5,000 @ $20 | EDGAR |
| 2025-01-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 37,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 3,594 @ $15 | EDGAR |
| 2024-12-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 10,099 @ $16.08 | EDGAR |
| 2024-02-23 | 4/A | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 22,000 @ $0 | EDGAR |
| 2024-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 21,300 @ $0 · Grant/award (A): 86,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1653881 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →